Results 1 to 10 of about 4,517,311 (361)

The Case for Anticoagulant Therapy [PDF]

open access: bronzeCirculation, 1964
In summary, the total world evidence suggests that in the absence of compelling contraindications and with the availability of satisfactory laboratory and clinical facilities, patients suffering with acute myocardial infarction should receive adequate anticoagulant therapy during the first month, and that the risk of reinfarction and death is reduced ...
Irving S. Wright
openalex   +4 more sources

A Guide to Anticoagulant Therapy [PDF]

open access: bronzeCirculation, 1961
The physician who undertakes anticoagulant therapy tampers with one of the most important homeostatic functions of the body. In so doing, he subjects the patient to the calculated hazard of possible hemorrhage balanced against the risks of the thrombosis or embolism that he seeks to prevent or treat.
Benjamin Alexander, Stanford Wessler
openalex   +5 more sources

Anticoagulant therapy in pediatrics [PDF]

open access: yesJournal of Basic and Clinical Pharmacy, 2014
Thromboembolic episodes are disorders encountered in both children and adults, but relatively more common in adults. However, the occurrence of venous thromboembolism and use of anticoagulants in pediatrics are increasing. Unfractionated Heparin (UH) is used as a treatment and prevention of thrombosis in adults and critically ill children.
Mariam Dabbous, Fouad Sakr, Diana Malaeb
openaire   +4 more sources

Effectiveness of anticoagulant therapy using heparin combined with Plavix after Rex shunt. [PDF]

open access: yesFront Pediatr
PurposeRex shunt is an optimal surgery for the treatment of extra-hepatic portal venous obstruction (EHPVO) in children. Anticoagulant therapy has been used to keep the patency of the bypass vein in the Rex shunt.
Zhang J, Li L.
europepmc   +2 more sources

Oral anticoagulant therapy

open access: yesIndian Journal of Dental Research, 2012
Pankaj Agarwal
doaj   +4 more sources

Retroperitoneal hematoma: An unexpected complication of anticoagulant therapy in COVID-19 patients [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2023
Introduction. Coronavirus disease 2019 (COVID-19) is associated with high inflammatory response, hemostatic disturbances, and high thrombotic risk. Despite thromboprophylaxis, a high incidence of thromboembolic events has been reported with a consequent ...
Vasković Igor   +4 more
doaj   +1 more source

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

open access: yesGut, 2021
This is a collaboration between the British Society of Gastroenterology (BSG) and the European Society of Gastrointestinal Endoscopy (ESGE), and is a scheduled update of their 2016 guideline on endoscopy in patients on antiplatelet or anticoagulant ...
A. Veitch   +11 more
semanticscholar   +1 more source

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.

open access: yesJournal of the American Medical Association (JAMA), 2022
Importance Among patients younger than 21 years of age, the optimal duration of anticoagulant therapy for venous thromboembolism is unknown. Objective To test the hypothesis that a 6-week duration of anticoagulant therapy for provoked venous ...
N. Goldenberg   +14 more
semanticscholar   +1 more source

Age-related differences in the survival benefit of the administration of antithrombin, recombinant human thrombomodulin, or their combination in sepsis

open access: yesScientific Reports, 2022
Disseminated intravascular coagulation (DIC) is one of the major organ dysfunctions associated with sepsis. This retrospective secondary analysis comprised data from a prospective multicenter study to investigate the age-related differences in the ...
Takeshi Wada   +30 more
doaj   +1 more source

Home - About - Disclaimer - Privacy